Neogenix Oncology, Inc. (Neogenix) announced today that it is entering a research collaboration with IRCCS San Raffaele Pisana in Rome, Italy led by Dr. Fiorella Guadagni. This research agreement reflects the ongoing expansion of Neogenix's collaboration strategy and aims to accelerate the development of a rapid antibody based diagnostic test. The opportunity to access a broad range of clinical samples will provide clinical data to support both a stand-alone and companion diagnostic approach within Neogenix...
More...
More...